Thank you for your constructive comment. Yeah, the Israel's study excluded the most vulnerable populations in long-term care facilities. And previous research from Norway did suggest that the risk-benefit assessment of vaccines in this population may be different than usual.

It's true that the actual numbers of vaccinated will be higher than infected individuals in the real-world settings. But even if this means that the adverse events from vaccines would be ~8-times higher than SARS-CoV-2 infections in the real world, I think the risk-benefit assessments still favor the vaccine. In the studies mentioned in this article, the risk ratio and difference for some adverse events easily exceeded >10-times already when comparing infection vs.vaccine. This number would be even higher when comparing deaths and perhaps post-covid syndrome too.

Plus, with the transmissibility of SARS-CoV-2, I think infection is a matter of when, not if. Anyhow, this is just what I think at present. I could be wrong and my views may change depending on what studies will come out in the future.